Phase I and pharmacokinetic study of irofulven, a novel mushroom-derived cytotoxin, administered for five consecutive days every four weeks in patients with advanced solid malignancies

S. G. Eckhardt, S. D. Baker, C. D. Britten, M. Hidalgo, L. Siu, L. A. Hammond, M. A. Villalona-Calero, S. Felton, R. Drengler, J. G. Kuhn, G. M. Clark, S. L. Smith, J. R. MacDonald, C. Smith, J. Moczygemba, S. Weitman, D. D. Von Hoff, E. K. Rowinsky

Research output: Contribution to journal › Article › peer-review